Noverasco di Opera, Italy

Saverio Minucci

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Noverasco Opera, IT (2010 - 2012)
  • Opera, IT (2010 - 2014)
  • Noverasco di Opera, IT (2013 - 2015)
  • Milan, IT (2024)

Company Filing History:


Years Active: 2010-2024

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Saverio Minucci: A Pioneer in Histone Deacetylase Inhibitors

Introduction

Saverio Minucci, an innovative inventor from Noverasco di Opera, Italy, has made significant contributions in the field of medicinal chemistry. With a portfolio of 11 patents, his work has focused primarily on developing new histone deacetylase inhibitors, which have important implications for cancer treatment and other diseases.

Latest Patents

Minucci's recent patents showcase his cutting-edge research on spirocyclic derivatives as histone deacetylase inhibitors. The first patent describes new compounds according to a complex general formula, where the structure allows for various substitutions providing enhanced efficacy as histone deacetylase inhibitors. The second patent similarly emphasizes the development of spirocyclic derivatives with specific structural features that enhance their potential as pharmaceutical agents. Both inventions include details on the compounds' acceptable salts, highlighting their suitability for therapeutic application.

Career Highlights

Throughout his career, Saverio Minucci has worked with notable institutions, including Dac S.r.l. and the Università degli Studi di Roma “La Sapienza.” His dedication to research and development has positioned him as a noteworthy figure in his field, particularly in the innovative strategies for drug design and development.

Collaborations

Minucci has collaborated with distinguished colleagues like Marco Ballarini and Mario Varasi, working together on groundbreaking projects that contribute to advancements in pharmaceuticals. These collaborations have fostered a dynamic exchange of ideas, enhancing the research outcomes and leading to innovative discoveries.

Conclusion

Saverio Minucci's inventive spirit and leadership in the development of histone deacetylase inhibitors have made a significant impact on medicinal chemistry. His numerous patents underline his commitment to innovation and the potential to revolutionize therapeutic practices. As he continues to explore new horizons in his research, the scientific community eagerly anticipates his future contributions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…